Skip to content

Clinical trials

Heart Diseases trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Country / region: Brazil Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20061
20081
20093
20103
20112
20123
20132
20141
20151
20173
20185
20191
20202
20213
20221
20235
20242
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting9
Unknown status7
Active, not recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Instituto de Cardiologia do Rio Grande do Sul5
University of Sao Paulo5
Eidos Therapeutics, a BridgeBio company2
Eli Lilly and Company2
Federal University of Minas Gerais2
GlaxoSmithKline2
Weill Medical College of Cornell University2
Abbott Medical Devices1
Alexandra Cristina Senegaglia1
Alexion Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases47
Coronary Artery Disease13
Cardiovascular Diseases12
Coronary Disease8
Atherosclerosis6
Heart Failure5
Acute Coronary Syndrome4
Atrial Fibrillation4
Heart Valve Diseases4
Stroke4

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.